Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Differences in Metabolic and Cardiovascular Effects of Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes

NCT00609856 is registered in ClinicalTrials.gov with Skane University Hospital as lead sponsor.

NCT NCT00609856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00609856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Differences in Metabolic and Cardiovascular Effects of Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes
Lead sponsor
Skane University Hospital
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2004
Completion date
December 31, 2006
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

secondary drug failure, type 2 diabetes